Latest Breaking News On - லாரன்ஸ் ஸ்டெய்ன்மேன் - Page 1 : comparemela.com
Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
A Less Expensive, More Convenient Treatment Option for MS?
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Form 8-K 180 Life Sciences Corp For: Jun 09
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share:
near term COVID-19 vaccination allocations to follow
TORONTO, May 17, 2021 (GLOBE NEWSWIRE)
Medivolve Inc. ( Medivolve ) ((NEO:MEDV, OTC:COPRF, FRA:4NC)) a healthcare technology and services company, today announced it has signed a binding agreement to acquire 100% of all outstanding shares of Marbella, a nonsterile compounded California state licensed and insured pharmacy. This acquisition advances Medivolve s growth strategy and expands its ability to deliver patient care through immediate access to pharmaceutical distribution throughout the state of California. The acquisition of Marbella Pharmacy is an important step forward in executing on our strategic growth strategy, said David Preiner, CEO of Medivolve. With Marbella, we have access to distribute pharmaceuticals, and soon COVID-19 vaccinations in the fifth-largest economy in the world. We will continue to invest in the resources and partnerships that advance our mission to harness the transformative power